Literature DB >> 31494486

The Value of a Statistical Life-Year in Sub-Saharan Africa: Evidence From a Large Population-Based Survey in Tanzania.

Bryan N Patenaude1, Innocent Semali2, Japhet Killewo2, Till Bärnighausen3.   

Abstract

BACKGROUND: The value of a statistical life-year (VSLY) is the central number for the economic allocation of health resources. Nevertheless, empirical data on VSLY are lacking for most low- and middle- income countries. In the absence of empirically established VSLY, researchers typically use an arbitrary 3-times multiple of per-capita gross domestic product or per-capita income per life-year saved to establish cost-effectiveness.
OBJECTIVE: In this study, we establish an empirical VSLY for the first time for a community in sub-Saharan Africa.
METHODS: To empirically establish VSLY, we randomly selected 4000 individuals in the Ukonga community of Tanzania and employed a contingent valuation survey to measure VSLY. Using the contingent valuation methodology, we elicited willingness to pay for a 2% mortality risk reduction and had individuals convert this into an annualized payment to be paid each year over their expected remaining life.
RESULTS: We compared our elicited value to per-capita income and found that mean VSLY is $9340 (95% CI $6206-$12 373). The mean annual income in our sample was $2069, resulting in a VSLY that is equivalent to 4.5 times per-capita income.
CONCLUSION: Our results provide empirical evidence to support moving away from using the World Health Organization cost-effectiveness thresholds in practice because they will likely result in inefficient underinvestment in cost-effective interventions, even in relatively poor samples.
Copyright © 2019 ISPOR–The professional society for health economics and outcomes research. Published by Elsevier Inc. All rights reserved.

Keywords:  cost-effectiveness; economic evaluation; health policy; public health; stated preference

Mesh:

Year:  2019        PMID: 31494486     DOI: 10.1016/j.vhri.2019.07.009

Source DB:  PubMed          Journal:  Value Health Reg Issues        ISSN: 2212-1099


  5 in total

1.  Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda.

Authors:  Olivia Ferguson; Youngji Jo; Jeff Pennington; Karl Johnson; Richard E Chaisson; Gavin Churchyard; David Dowdy
Journal:  J Int AIDS Soc       Date:  2020-10       Impact factor: 5.396

2.  Value of statistical life year in extreme poverty: a randomized experiment of measurement methods in rural Burkina Faso.

Authors:  Stefan T Trautmann; Yilong Xu; Christian König-Kersting; Bryan N Patenaude; Guy Harling; Ali Sié; Till Bärnighausen
Journal:  Popul Health Metr       Date:  2021-11-17

3.  Cost-effectiveness analysis of human-centred design for global health interventions: a quantitative framework.

Authors:  Chen Liu; Jae Hyoung Lee; Patricia Turimumahoro; J Lucian Davis; David Dowdy; Amanda J Gupta; Austin Tucker; Chris Larkin; Achilles Katamba
Journal:  BMJ Glob Health       Date:  2022-03

4.  Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life.

Authors:  Dan Cai; Si Shi; Shan Jiang; Lei Si; Jing Wu; Yawen Jiang
Journal:  Eur J Health Econ       Date:  2021-10-16

5.  Pediatric surgery backlog at a Ugandan tertiary care facility: COVID-19 makes a chronic problem acutely worse.

Authors:  Greg Klazura; Phyllis Kisa; Anne Wesonga; Mary Nabukenya; Nasser Kakembo; Stella Nimanya; Rovine Naluyimbazi; John Sekabira; Doruk Ozgediz; Monica Langer
Journal:  Pediatr Surg Int       Date:  2022-07-29       Impact factor: 2.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.